Theragent is a full-service, cGMP-compliant cell and gene therapy CDMO based in southern California. Founded in 2019, Theragent specializes in developing and manufacturing novel personalized immunotherapies for cancer patients around the world. They have two facilities in the southern California area that provide R&D, cell line generation, proof of concept, viral production, process development, analytical development, and clinical production to their clients.
Visit Company Website
